Harned lowered his rating on the aircraft maker’s shares to underperform from market perform. He also cut his share-price target to $199 from $221.
“We had seen Boeing as fairly valued since the stock rose after announcements on high efficacy vaccines for covid-19,” Harned wrote in a commentary. Harned mentioned that while the 737 MAX is now in service and deliveries have restarted, it is slightly behind the analyst’s forecast.
He also said that the five-year delivery and free cash flow outlook was only about half of his team’s 2018 outlook.
The analyst also pointed out that recently the 787 "has come under more pressure, which we do not believe the market fully appreciates.” This led him to lower 2020-21 free-cash flow estimates. "We estimate 787 issues could significantly hurt free cash flow through cost of repairs, compensation to customers, timing of engine cash payments, and less operating leverage", Harned noted .